Biologics and Biosimilars

Drug Discovery and Clinical Applications
Herausgeber: Malhotra, Ashim; Feng, Xiaodong; Xie, Hong-Guang; Yang, Catherine F.

• Gebundenes Buch

Produktbeschreibung

This is a good book designed mainly to give students and clinicians a quick overview of the science, principles, and applications of biologics and biosimilars. It is a useful tool in the clinic setting. - Victor Nwoko, BA, PharmD, Lifespring Pharmacy Inc.

Produktdetails

• Verlag: Taylor & Francis Ltd
• Seitenzahl: 510
• Erscheinungstermin: 14. Juni 2022
• Englisch
• Abmessung: 260mm x 182mm x 35mm
• Gewicht: 1142g
• ISBN-13: 9781138594227
• ISBN-10: 1138594229
• Artikelnr.: 63118331

Autorenporträt

Xiaodong Feng, Hong-Guang Xie, Ashim Malhotra, Catherine F. Yang

Inhaltsangabe

Chapter 1: Biologics and Biosimilars 101: Principles and Practice. Chapter
2: Frontiers in Biopharmaceutical Development of Biologics and Biosimilars:
Opportunities and Challenges Chapter 3: Biologics and Biosimilars: Research
and Development. Chapter 4: Vaccines as Biologics in the Era of Pandemic.
Chapter 5: Therapeutic Delivery Systems for Biologics and Biosimilars.
Chapter 6: Legislative and Regulatory Pathways for Biosimilars. Chapter 7:
The Development of Biologics from the Perspective of the Pharmaceutical
Industry. Chapter 8: The Manufacturing and Quality Assurance Process for
Biologics and Biosimilars. Chapter 9: Biopharmaceutics, Pharmacokinetics,
and Pharmacodynamics of Biological Products. Chapter 10: Understanding
Variability, Stability, and Immunogenicity of Biosimilars. Chapter 11:
Expanding the Product Shelf: Taking Biologics and Biosimilars from the
Bench to the Bedside. Chapter 12: Hydrogel-Based Delivery of Biologics in
Cancer and Cardiovascular Diseases: Proof-of-Concept. Chapter 13: Clinical
Use of Biologics and Biosimilars in Oncology Settings. Chapter 14:
Monoclonal Antibodies in Cancer Therapeutics. Chapter 15: Molecule-Targeted
Drugs That Treat Colorectal Cancer. Chapter 16: Rising from the Ashes: The
Curious Case of the Development of Biologics for the Treatment of
Neuroblastoma. Chapter 17: Paradigm Shift in Cancer Therapy: Chimeric
Antigen Receptor T Cell Therapy. Chapter 18: Biologics and Biosimilars Used
for Diabetes. Chapter 19: Clinical Use of Biologics and Biosimilars in
Asthma. Chapter 20: Biologics and Biosimilars: Potential Therapeutics for
Autoimmune Renal Diseases. Chapter 21: Therapeutics of Recombinant Human
Clotting Factor VIII (rhFVIII) for Hemophilia A. Chapter 22: Complement as
New Immunotherapy Target: Past, Present, and Future. Chapter 23: Drug
Discovery Approaches for Inflammatory Bowel Disease: Antibodies and
Biosimilars. Chapter 24: Transformative Stem Cell-Based Therapy in
Neurological Diseases and Beyond. Chapter 25: Biologics and Biosimilars:
Clinical Applications and Biomarker Testing. Chapter 26: Application of
Modeling and Simulation in the Development of Biologics and Biosimilars.
Chapter 27 Machine Learning Applications in Biologics and Biosimilars:
Disruptive Innovation.